By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Magellan Biosciences today announced a deal with Bruker combining their technologies for microbial identification.

Under the terms of the deal, Magellan will develop and test an integrated cross-platform software interface for microbial identification gathered on Bruker's MALDI Biotyper mass spectrometer-based platform combined with results from Magellan's Trek-brand Sensititre susceptibility-testing platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.